Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Revisiting long-standing biological questions through evolving technologies.

Bioscience trends·2026

Same author

RNA activation as a precision dosing modality: MTL-CEBPA for controlled enzyme elevation in MPS I-H.

Frontiers in medicine·2026

Same author

C/EBPβ stabilizes oxidative stress in triple-negative breast cancer cells, driving taxane resistance and immune evasion.

Molecular therapy : the journal of the American Society of Gene Therapy·2025

Same author

ASOs reduce SARS-CoV-2 viral titers in Syrian golden hamsters.

Molecular therapy. Nucleic acids·2025

Same author

A hypoxia-responsive tRNA-derived small RNA confers renal protection through RNA autophagy.

Science (New York, N.Y.)·2025

Same author

Small RNAs as therapeutic agents: From catalytic motifs to regulatory pathways.

Molecular therapy : the journal of the American Society of Gene Therapy·2025

Same journal

A DNA-guided prokaryotic argonaute enables programmable RNA cleavage for sequencing and quality control of <i>in vitro</i>-transcribed RNAs.

Molecular therapy. Nucleic acids·2026

Same journal

Enhanced γ-globin reactivation and sickle cell correction through a repressor-to-activator motif switch in the <i>HBG1/2</i> promoters.

Molecular therapy. Nucleic acids·2026

Same journal

Optimizing twin prime editing components for scalable genome editing and therapy in spinocerebellar ataxia type 3.

Molecular therapy. Nucleic acids·2026

Same journal

Enhancing protein expression in humans through codon optimization with transformer and contrastive learning.

Molecular therapy. Nucleic acids·2026

Same journal

Neonatal expression of human FMRP isoform corrects cortical deficits and improves behavior in a mouse model of fragile X syndrome.

Molecular therapy. Nucleic acids·2026

Same journal

Meta-analysis of adverse events in clinical studies with antisense oligonucleotide therapies.

Molecular therapy. Nucleic acids·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 7, 2025

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay

Published on: February 28, 2015

A new program for SELEX sorting and visualization of aptamers

¹Center for RNA Biology and Therapeutics Beckman Research Institute of the City of Hope, Duarte, CA, USA.

Molecular Therapy. Nucleic Acids

|January 6, 2025

Summary

No abstract available in PubMed .

More Related Videos

Primer-Free Aptamer Selection Using A Random DNA Library

Primer-Free Aptamer Selection Using A Random DNA Library

Published on: July 26, 2010

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

Related Experiment Videos

Last Updated: May 7, 2025

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay

Published on: February 28, 2015

Primer-Free Aptamer Selection Using A Random DNA Library

Primer-Free Aptamer Selection Using A Random DNA Library

Published on: July 26, 2010

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022